The socio-economic impact of work disability due to inflammatory bowel disease in Brazil-Reference-Cited by-同舟云学术

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil

Published:2017-05-18 Issue:3 Volume:19 Page:463-470
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

de S. B. Fróes Renata,Carvalho Ana Teresa Pugas,de V. Carneiro Antonio Jose,de Barros Moreira Adriana Maria Hilu,Moreira Jessica P. L.,Luiz Ronir R.,de Souza Heitor S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/article/10.1007/s10198-017-0896-4/fulltext.html

Reference37 articles.

1. Abraham, B.P., Sellin, J.H.: Disability in inflammatory bowel disease. Gastroenterol. Clin. North Am. 41, 429–441 (2012)

2. Ananthakrishnan, A.N., Weber, L.R., Knox, J.F., et al.: Permanent work disability in Crohn’s disease. Am. J. Gastroenterol. 103, 154–161 (2008)

3. Bassi, A., Dodd, S., Williamson, P., et al.: Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53, 1471–1478 (2004)

4. Bernklev, T., Jahnsen, J., Henriksen, M., et al.: Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 12, 402–412 (2006)

5. Bodger, K., Yen, L., Szende, A., et al.: Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis. Eur. J. Gastroenterol. Hepatol. 26, 213–221 (2014)

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB;Scientific Reports;2024-02-21

2. Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease: what is the opportunity cost of improving access to healthcare?;Internal Medicine Journal;2024-01-12

3. HOSPITALIZATION, USE OF BIOLOGICS AND SURGERY RATES IN INFLAMMATORY BOWEL DISEASES: A SINGLE-CENTRE COMPARATIVE ANALYSIS BETWEEN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS IN A TERTIARY UNIT FROM LATIN AMERICA;Arquivos de Gastroenterologia;2024

4. Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases;Journal of Clinical Medicine;2023-04-03

5. INCIDENCE, PREVALENCE, AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN THE STATE OF PARANÁ IN SOUTHERN BRAZIL;Arquivos de Gastroenterologia;2022-09